Explore more topics
SEC Form 4 research

Solid Biosciences Inc. insider transactions

Inspect Solid Biosciences Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001707502
Reporting owners
59
Officers and directors
30
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 37 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Ziolkowski Jennifer Lynn00017274103
Bain Capital Life Sciences Partners, LP000170303015
Morris Carl Ashley00017275717
Koppel Adam000157896528
Tan Kevin00018840568
Cumbo Alexander000168599415
BCIP Life Sciences Associates, LP000170292119
RA Capital Nexus Fund, L.P.0001780117116
Bain Capital Life Sciences Investors, LLC000170303130
Bain Capital Life Sciences Investors II, LLC00017961555
Bain Capital Life Sciences Fund II, L.P.00017731875
Zarur Juan Andrey00017274042
Perceptive Xontogeny Venture Fund, LP000175794018
Amorrortu Pedro Alvaro00017275526
Arnold Matthew Bennett00017279913
BCLS II Equity Opportunities GP, LLC00020081741
BCLS II Equity Opportunities, LP00018144741
BCLS II Investco (GP), LLC00018191015
BCLS II Investco, LP00018188935
BCLS SB Investco, LP00017280561
Brooks Gabriel00019978095
EDELMAN JOSEPH0001164426717
Ganot Ilan000172746021
Hanrahan Jessie00019548267
HERSCHA LYNETTE00017081981
Herzich Paul00019549917
Howton David T000152929725
Kahn Clare00018492362
Kolchinsky Peter00013848591,083
Marlowe Jennifer00019558711
PERCEPTIVE ADVISORS LLC0001224962733
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD0001249675712
Quiroz Jorge Armando00017274015
RA Capital Healthcare Fund LP00013150821,055
RA CAPITAL MANAGEMENT, L.P.00013468241,081
Schneider Joel Solomon Zev00017276498
Shah Rajeev M.0001619841388

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.